Physical Activity in CKD
Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Oct 1, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Physical Activity in CKD," aims to explore how a 12-week program of physical activity can help adolescents with chronic kidney disease (CKD). The study will involve 64 young people between the ages of 13 and 18 who have CKD but are not yet on dialysis or have had a kidney transplant. To participate, adolescents must be able to speak English and have permission from a parent or guardian. Caregivers of these adolescents can also take part in the study as long as they meet the language requirements.
During the trial, participants can expect to engage in guided physical activities designed to improve their health and well-being. However, there are some eligibility criteria—adolescents who are pregnant, already very active, or have certain medical conditions that make it unsafe to exercise will not be able to join. This study is still in the planning phase and has not started recruiting participants yet. Overall, the trial seeks to understand the benefits of physical activity for young people living with CKD, and it could provide valuable insights into improving their health outcomes.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- For adolescent participants:
- • 1. Males or females age 13 - 18 years
- • 2. Diagnosis of CKD stage II - V not yet on dialysis or with a transplant
- • 3. English proficiency
- • 4. Parental/guardian permission (informed consent), and if applicable, child assent
- For caregiver participants:
- • 1. Parent/legal guardian of an enrolled adolescent participant
- • 2. English proficiency
- Exclusion Criteria:
- For adolescent participants:
- • 1. Pregnant or lactating
- • 2. Non-ambulatory
- • 3. Have high physical activity at baseline (\>45 min/day of MVPA)
- • 4. Provide \<2 days of physical activity data during the run-in period
- • 5. Have a condition, such as heart or lung disease, that preclude safely engaging in physical activity
- • 6. Have received a solid organ transplant
- • 7. Have limited English proficiency
- • 8. Are on dialysis
- • 9. In the opinion of the investigator, are unable to comply with the requirements of the study protocol or are unsuitable for the study for any reason
- For caregivers participants:
- • 1. Limited English proficiency
About Children's Hospital Of Philadelphia
The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Amy Kogon, MD MPH
Principal Investigator
Children's Hospital of Philadelphia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported